Asian Phytoceuticals PCL
SET:APCO
Asian Phytoceuticals PCL?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2.64
6.4
|
Price Target |
|
We'll email you a reminder when the closing price reaches THB.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Asian Phytoceuticals PCL hold over its rivals?
What risks and challenges
does Asian Phytoceuticals PCL face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Asian Phytoceuticals PCL.
Provide an overview of the primary business activities
of Asian Phytoceuticals PCL.
What unique competitive advantages
does Asian Phytoceuticals PCL hold over its rivals?
What risks and challenges
does Asian Phytoceuticals PCL face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Asian Phytoceuticals PCL.
Provide P/S
for Asian Phytoceuticals PCL.
Provide P/E
for Asian Phytoceuticals PCL.
Provide P/OCF
for Asian Phytoceuticals PCL.
Provide P/FCFE
for Asian Phytoceuticals PCL.
Provide P/B
for Asian Phytoceuticals PCL.
Provide EV/S
for Asian Phytoceuticals PCL.
Provide EV/GP
for Asian Phytoceuticals PCL.
Provide EV/EBITDA
for Asian Phytoceuticals PCL.
Provide EV/EBIT
for Asian Phytoceuticals PCL.
Provide EV/OCF
for Asian Phytoceuticals PCL.
Provide EV/FCFF
for Asian Phytoceuticals PCL.
Provide EV/IC
for Asian Phytoceuticals PCL.
What are the Revenue projections
for Asian Phytoceuticals PCL?
How accurate were the past Revenue estimates
for Asian Phytoceuticals PCL?
What are the Net Income projections
for Asian Phytoceuticals PCL?
How accurate were the past Net Income estimates
for Asian Phytoceuticals PCL?
What are the EPS projections
for Asian Phytoceuticals PCL?
How accurate were the past EPS estimates
for Asian Phytoceuticals PCL?
What are the EBIT projections
for Asian Phytoceuticals PCL?
How accurate were the past EBIT estimates
for Asian Phytoceuticals PCL?
Compare the revenue forecasts
for Asian Phytoceuticals PCL with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Asian Phytoceuticals PCL and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Asian Phytoceuticals PCL against its competitors.
Analyze the profit margins
(gross, operating, and net) of Asian Phytoceuticals PCL compared to its peers.
Compare the P/E ratios
of Asian Phytoceuticals PCL against its peers.
Discuss the investment returns and shareholder value creation
comparing Asian Phytoceuticals PCL with its peers.
Analyze the financial leverage
of Asian Phytoceuticals PCL compared to its main competitors.
Show all profitability ratios
for Asian Phytoceuticals PCL.
Provide ROE
for Asian Phytoceuticals PCL.
Provide ROA
for Asian Phytoceuticals PCL.
Provide ROIC
for Asian Phytoceuticals PCL.
Provide ROCE
for Asian Phytoceuticals PCL.
Provide Gross Margin
for Asian Phytoceuticals PCL.
Provide Operating Margin
for Asian Phytoceuticals PCL.
Provide Net Margin
for Asian Phytoceuticals PCL.
Provide FCF Margin
for Asian Phytoceuticals PCL.
Show all solvency ratios
for Asian Phytoceuticals PCL.
Provide D/E Ratio
for Asian Phytoceuticals PCL.
Provide D/A Ratio
for Asian Phytoceuticals PCL.
Provide Interest Coverage Ratio
for Asian Phytoceuticals PCL.
Provide Altman Z-Score Ratio
for Asian Phytoceuticals PCL.
Provide Quick Ratio
for Asian Phytoceuticals PCL.
Provide Current Ratio
for Asian Phytoceuticals PCL.
Provide Cash Ratio
for Asian Phytoceuticals PCL.
What is the historical Revenue growth
over the last 5 years for Asian Phytoceuticals PCL?
What is the historical Net Income growth
over the last 5 years for Asian Phytoceuticals PCL?
What is the current Free Cash Flow
of Asian Phytoceuticals PCL?
Discuss the annual earnings per share (EPS)
trend over the past five years for Asian Phytoceuticals PCL.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
TH |
A
|
Asian Phytoceuticals PCL
SET:APCO
|
1.9B THB | 23.3 | |
FR |
![]() |
L'Oreal SA
PAR:OR
|
200.2B EUR | 19.2 |
|
UK |
![]() |
Unilever PLC
LSE:ULVR
|
110.7B GBP | 145.8 |
|
IN |
![]() |
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.7T INR | 37.4 |
|
UK |
![]() |
HALEON PLC
LSE:HLN
|
33.1B GBP | 13.8 |
|
US |
![]() |
Estee Lauder Companies Inc
NYSE:EL
|
32.5B USD | 17.2 |
|
DE |
![]() |
Beiersdorf AG
XETRA:BEI
|
24.9B EUR | 11.4 |
|
JP |
![]() |
Kao Corp
TSE:4452
|
3.1T JPY | 12.5 |
|
IN |
![]() |
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.2T INR | 40.5 |
|
IN |
![]() |
Dabur India Ltd
NSE:DABUR
|
906.3B INR | 38.3 |
|
CA |
![]() |
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD | -6 373.4 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
TH |
A
|
Asian Phytoceuticals PCL
SET:APCO
|
Average EV/EBITDA:
35.9
23.3
|
N/A | N/A | |
FR |
![]() |
L'Oreal SA
PAR:OR
|
19.2
|
6%
|
3.2 |
|
UK |
![]() |
Unilever PLC
LSE:ULVR
|
145.8
|
3%
|
48.6 |
|
IN |
![]() |
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
37.4
|
8%
|
4.7 |
|
UK |
![]() |
HALEON PLC
LSE:HLN
|
13.8
|
5%
|
2.8 |
|
US |
![]() |
Estee Lauder Companies Inc
NYSE:EL
|
17.2
|
3%
|
5.7 |
|
DE |
![]() |
Beiersdorf AG
XETRA:BEI
|
11.4
|
2%
|
5.7 |
|
JP |
![]() |
Kao Corp
TSE:4452
|
12.5
|
7%
|
1.8 |
|
IN |
![]() |
Godrej Consumer Products Ltd
NSE:GODREJCP
|
40.5
|
14%
|
2.9 |
|
IN |
![]() |
Dabur India Ltd
NSE:DABUR
|
38.3
|
12%
|
3.2 |
|
CA |
![]() |
Relevium Technologies Inc
XTSX:RLV
|
Negative Multiple: -6 373.4 | N/A | N/A |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.